Tempus AI, Inc. (NASDAQ:TEM) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Tempus AI, Inc. (NASDAQ:TEM) have received a consensus recommendation of “Moderate Buy” from the twelve research firms that are covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $56.00.

Several research firms have weighed in on TEM. Stifel Nicolaus lowered Tempus AI from a “buy” rating to a “hold” rating and boosted their price target for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Bank of America boosted their target price on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a report on Friday, December 13th. Loop Capital upped their price target on shares of Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a research report on Tuesday, October 15th. Guggenheim initiated coverage on shares of Tempus AI in a research report on Monday, December 9th. They issued a “buy” rating and a $74.00 price objective for the company. Finally, Wolfe Research started coverage on shares of Tempus AI in a report on Friday, December 13th. They issued an “outperform” rating and a $60.00 target price on the stock.

Insider Buying and Selling

In other Tempus AI news, COO Ryan Fukushima sold 120,000 shares of the stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $42.51, for a total transaction of $5,101,200.00. Following the transaction, the chief operating officer now owns 1,007,207 shares in the company, valued at $42,816,369.57. This represents a 10.65 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Eric P. Lefkofsky sold 187,655 shares of Tempus AI stock in a transaction that occurred on Wednesday, December 18th. The shares were sold at an average price of $37.54, for a total transaction of $7,044,568.70. Following the completion of the sale, the chief executive officer now owns 9,557,283 shares of the company’s stock, valued at approximately $358,780,403.82. The trade was a 1.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 845,041 shares of company stock valued at $35,125,473.

Institutional Trading of Tempus AI

Large investors have recently modified their holdings of the stock. First Horizon Advisors Inc. acquired a new stake in shares of Tempus AI during the 3rd quarter worth approximately $30,000. Sandia Investment Management LP acquired a new stake in shares of Tempus AI in the 2nd quarter valued at $136,000. Vestor Capital LLC acquired a new stake in shares of Tempus AI in the 3rd quarter valued at $153,000. Stifel Financial Corp bought a new position in shares of Tempus AI in the 3rd quarter valued at $218,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd acquired a new position in shares of Tempus AI during the 3rd quarter worth $258,000. 24.22% of the stock is owned by institutional investors and hedge funds.

Tempus AI Trading Up 6.6 %

TEM opened at $40.76 on Tuesday. The business’s 50-day simple moving average is $48.88 and its 200 day simple moving average is $46.95. Tempus AI has a 52-week low of $22.89 and a 52-week high of $79.49. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.